Screen Readers Skip to Content

Treating Diabetes Without Insulin

Published: 2011-02-14
Author: Children's Hospital Boston

Synopsis: Normalizing blood sugar that does not involve insulin and could offer a new therapeutic approach to both kinds of diabetes. New approach lowers blood sugar in both type 1 and type 2 diabetes.

advertisements

Main Digest

New approach lowers blood sugar in both type 1 and type 2 diabetes.

Other Diabetes Information Publications (65)

Diabetes can result from either a deficiency of insulin (type 1 or insulin-dependent diabetes) or decreased sensitivity to insulin (type 2 diabetes). Researchers at Children's Hospital Boston have discovered a mechanism for normalizing blood sugar that doesn't involve insulin and could offer a new therapeutic approach to both kinds of diabetes.

Reporting in Nature Medicine online on February 13, Umut Ozcan, MD, and colleagues in Children's Division of Endocrinology show that a regulatory protein called XBP-1s, when activated artificially in the liver, can normalize high blood sugar in both lean, insulin-deficient type 1 diabetic mice and obese, insulin-resistant type 2 diabetic mice. This suggests that approaches aimed at increasing XBP-1s activity may benefit patients with either type of diabetes.

In previous work, Ozcan's lab identified XBP-1s as a key to the body's sensitivity to insulin, and shown that its function is impaired in the presence of obesity. Initially, XBP-1s was thought to increase insulin sensitivity and normalize blood glucose by binding to DNA and relieving stress on the endoplasmic reticulum, a cellular organ that assembles and folds proteins. When XBP-1s was artificially activated, "blood sugars in obese mice with type 2 diabetes came down abruptly," Ozcan says.

In the new study, Ozcan and colleagues show that XBP-1s regulates blood sugar in a second way: It causes the degradation of a protein, FoxO1, whose actions include increasing glucose output from the liver and stimulating feeding behavior in the brain. This degradation of FoxO1, the researchers show, is independent of XBP-1s' effect on the insulin signaling system, and by itself leads to a reduction in blood glucose levels and increased glucose tolerance (more rapid clearing of glucose from the blood).

"Activating XBP-1s could be another approach to type 2 diabetes, and could be very beneficial for type 1 diabetes, too," says Ozcan. "Even in mice with no insulin, increased expression of XBP-1s lowered the blood glucose level significantly. This suggests that approaches that activate XBP-1s in the liver of type 1 diabetics could control blood glucose levels, with potentially much less requirement for insulin."

Ozcan's lab is now seeking practical ways to activate XBP-1s that would lend themselves to clinical development. Currently the only treatment for type 1 diabetes is insulin, which requires injections and requires close monitoring to avoid hypoglycemia. Drugs are available for type 2 diabetes, but it remains difficult to control.

Yingjiang Zhou of Children's Division of Endocrinology was first author on the study. The study was funded by Children's Hospital Boston, the National Institutes of Health, and Timothy Murphy funds.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 12 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 392-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Children's visit: Vector Blog.

Post to Twitter Add to Facebook

Disabled World is an independent disability community established in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative news, reviews, sports, stories and how-tos. You can also connect with us on Twitter and Facebook or learn more about Disabled World on our about us page.

advertisements

Disabled World provides general information only. The materials presented are never meant to substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Financial support is derived from advertisements or referral programs, where indicated. Any 3rd party offering or advertising does not constitute an endorsement.


Cite This Page (APA): Children's Hospital Boston. (2011, February 14). Treating Diabetes Without Insulin. Disabled World. Retrieved July 4, 2022 from www.disabled-world.com/health/diabetes/treating.php

Permalink: <a href="https://www.disabled-world.com/health/diabetes/treating.php">Treating Diabetes Without Insulin</a>